[ Price : $8.95]
FDA issues an early alert warning healthcare providers about a potentially dangerous defect in certain angiographic syringes inclu...[ Price : $8.95]
FDA and CMS unveil a new joint initiative aimed at significantly shortening the time it takes for innovative medical devices to re...[ Price : $8.95]
FDA sends Grace Therapeutics a complete response letter rejecting approval for its experimental treatment GTx-104 (nimodipine), ci...[ Price : $8.95]
A Clinical Trial Vanguard column demonstrates how synthetic biology is outstripping FDAs regulatory framework under the Supreme Co...[ Price : $8.95]
FDA releases the form FDA-483 with five repeat observations from an inspection at Houston, TX-based Revive Rx Pharmacy.[ Price : $8.95]
Researchers describe FDA and congressional actions that will improve the ability of the new plausible mechanism pathway to lead to...[ Price : $8.95]
Gilead calls on FDA to rescind its decision to file a Cipla 505(b)(2) NDA for an apparent duplicate of Gileads Descovy.[ Price : $8.95]
FDA issues a Warning Letter to New Life Pharma citing serious manufacturing and regulatory violations tied to the companys product...